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Summary The glutathione S-transferases (GSTs) have been implicated in carcinogenesis and tumour drug-
therapy resistance. In this study GST pi was the predominant isoenzyme in the fetal human kidney. It was
present in differentiated epithelial structures but never in the primitive mesenchyme. By contrast most cases of
Wilms' tumours showed GST pi in both epithelial structures and undifferentiated blastema. The level of
expression, as assessed by immunostaining, was no more than moderate, and was generally higher in
differentiated elements. In only one case was GST alpha found in Wilms' tumour. This study has demon-
strated a difference between fetal kidney and Wilms' tumour blastema in terms of GST expression.
The glutathione S-transferases (GST) are a widely distributed
multigene family of enzymes which catalyse the conjugation
of reduced glutathione (GSH) with a variety of electrophiles,
including carcinogens and cytotoxic drugs (Jakoby, 1977;
Chasseaud, 1979; Mannervik, 1985). Three distinct cytosolic
isoenzyme groups exist, referred to as classes alpha, mu and
pi GST, or GST I, II and III (Mannervik, 1985; Hayes &
Mantle, 1986). Recently a distinct human microsomal GST
has been described and purified (McLellan et al., 1989). In
many malignant tumours the expression of GST is altered,
with an increase in GST pi frequently reported (Di Ilio et al.,
1987; Siegers et al., 1984; Batist et al., 1987; Tew et al., 1987;
Shea et al., 1988). This has been implicated in tumour cell
resistance to alkylating agents and other cytotoxic drugs
(Clapper et al., 1987; Wolf et al., 1987). However, most
studies in humans have used tumours which are only partly
sensitive or totally resistant to cytotoxic drugs. There is a
need for similar investigations into tumours known to be
responsive to cytotoxic drug therapy before any definite link
between GST expression and tumour drug sensitivity can be
assumed.
Wilms' tumour (nephroblastoma) is one of the commonest
solid tumours of childhood. It comprises undifferentiated
blastema containing differentiated tubules and glomeruloid
forms (Lawler et al., 1977; Beckwith & Palmer, 1978) which
morphologically and biochemically show similarities to the
embryonic metanephros which forms the kidney (Mierau et
al., 1987; Roth et al., 1988). Nephroblastoma generally res-
ponds well to chemotherapy (Lawler et al., 1977).
We have investigated the pattern of expression of GST
isoenzymes by immunohistochemistry during renal
ontogenesis and in Wilms' tumour. There were two aims in
this study: firstly, to identify the pattern of GST expression
during renal embryogenesis; secondly, to see if Wilm's
tumour shows similar expression to fetal kidney.
Materials and methods
Tissue
Material was obtained from routine autopsy of aborted
fetuses, or paediatric deaths where there was no evidence of
renal impairment. Thirteen kidneys, ranging from 12 weeks
gestation to 14 years of age, were included. Fifteen cases of
Wilms' tumour were also studied: tissue was obtained from
nephrectomy specimens. All tissue was formalin fixed and
embedded in paraffin wax. A brief clinical summary was
obtained. None of the patients had received previous
radiotherapy or chemotherapy.
Antibodies to GST
These were the kind gift of Drs J.D. Hayes and G.J. Beckett.
Specific polyclonal antisera to each cytosolic and microsomal
enzyme had been raised in rabbits by injecting purified GST
in complete Freund's adjuvant (Hayes et al., 1983, 1987;
Hayes & Mantle, 1986; McLellan et al., 1989). The
antibodies did not show any cross reactivity.
Immunostaining
This was based on the avidin-biotin-peroxidase system
previously described (Harrison et al., 1989a). Sections were
cut at 3glm, dewaxed and incubated with rabbit anti-GST for
I h at room temperature, diluted 1:200 in phosphate buffered
saline. After washing, antibody binding was detected using
biotinylated goat anti-rabbit IgG (Dako, UK) and an
avidin-peroxidase complex (Dako, UK). Diaminobenzidine
(Sigma, UK) was the peroxidase substrate; this gives an




Fetal tissues showed the expected morphological changes of
undifferentiated blastema within which tubules and glomeruli
appeared. Each case of Wilms' tumour was confirmed his-
tologically (Table I). In most cases some non-neoplastic
kidney was also present. This served as an internal positive
control for immunostaining.
Immunostainingfor GST
Fetal kidney For GST pi, the metanephric blastema did not
stain at any stage but tubules arising in the blastema stained
weakly at 12 weeks gestation. By 20 weeks gestation there
was strong staining of tubules and the plump parietal
epithelial cells of Bowman's capsule (Figure 1). The
glomerular tuft and mesenchymal stroma remained negative.
Both proximal and distal tubules were stained equally until
40 weeks gestation (Figure 2), after which the staining inten-
sity decreased in proximal tubules. At 14 years of age GST pi
was present in distal tubules, some parietal cells of Bowman's
capsule and weakly in podocytes (Figure 3).
For GST alpha, no staining at all was seen until 30 weeks
gestation. At this time individual cells in proximal tubules
stained (Figure 4). By three months of age many proximal
tubules were stained (Figure 5), and by 14 years of age all
proximal tubules were strongly positive for GST alpha
(Figure 6).
For GST mu, staining was very weak at all stages and no
relationship to gestational age was discerned.
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Table I Summary of details of patients with Wilms' tumour
Treatment Outcome
Patient Sex Age (years) Stage Surgery Chemo. Radio. (years) GST
1 M 0.4 I + + - Alive 2.5y Negative
2 F 0.9 I + + - Alive 6.6y pi
3 F 1.0 I + + - Alive 6.2y pi, focal alpha
4 F 6.2 I + + - Alive 1.6y pi
5 F 0.9 II + + - Alive 9.2y pi
6 M 2.1 II + + - Alive 3.8y pi
7 M 4.3 II + + + Alive 9.6y pi
8 M 6.2 II + + - Alive 2.3y pi
9 F 0.3 III + + - Died 1.4y pi
10 F 10.0 III + + + Alive 6.6y pi
II F 10.9 III + + + Died 1.3y pi
12 F 3.9 IV + + - Died 0.2y pi
13 M 4.3 IV + + + Alive 2.3y pi
14 F 7.3 IV + + - Alive 7.9y pi
15 F 9.3 IV + + - Alive 3.6y pi
All patients were classed as having favourable histology; that is, the absence of areas of anaplasia
(Beckwith, 1986).
Figure 1 Staining for GST pi of tubules and plump parietal
epithelium of Bowman's capsules. Twenty weeks gestation
( x 160).
Figure 2 At 40 weeks gestation both proximal and distal tubules
are stained for GST pi ( x 160).
Microsomal GST was variably expressed between cases
studied. In several cases endothelium was strongly stained
(Figure 7). No relationship to gestation was noted.
Wilms' tumour In one case for GST pi the undifferentiated
blastema was completely negative (Figure 8), but
differentiated tubular structures were weakly stained. The
remainder of cases showed moderate but variable staining of
the blastema for GST pi (Figure 9), although focally staining
was quite strong. Where epithelial differentiation occurred
the differentiated elements invariably expressed GST pi to
some extent (Figure 10). The difference in staining between
cases was thought to be real because the intensity of staining
Figure 3 At 14 years only distal tubules contain GST pi. There
is patchy staining of Bowman's capsule ( x 160).
Figure 4 At 36 weeks gestation there is a very focal proximal
tubular staining for GST alpha (x 160).
of non-neoplastic renal tissue did not show marked case to
case variation.
For GST alpha, one of the fifteen cases showed occasional
positively stained cells (Figure 11).
GST mu and microsomal GST were not detected in any
case. Prolonged incubation of sections with primary antisera
to GST alpha, mu and microsomal did suggest that there was
a low level of expression of these isozymes. However, the
increased background staining made definitive assessment
impossible, and biochemical analysis of fresh tissue would be
required to confirm or refute low level expression. Under
normal conditions GST pi was the only readily detectable
isoenzyme in most cases.838 D.J. HARRISON et al.
Figure 5 At 3 months postnatally many proximal tubules con-
tain GST alpha, but staining is of variable intensity ( x 160).
Figure 8 Residual normal tubules are stained for GST pi. The
Wilms' tumour blastema is not stained ( x 160).
Figure 6 GST alpha in proximal tubules at 14 years of age
(x 160).
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Figure 9 Weak staining of Wilms'
( x 320).
Figure 7 Microsomal GST in endothelium at 24 weeks gestation
( x 320).
Discussion
Biochemical studies have shown that GST pi is present
throughout ontogeny of the kidney and falls after birth. GST
alpha is only significantly expressed in late gestation and at
parturition, the level increasing until one year of age (Fauld-
ner et al., 1987; Hiley et al., 1989). This is in agreement with
our findings of GST pi expression accompanying the
differentiation of all epithelial renal structures from the
blastema, with later restriction to distal tubules. The
significance of the appearance of GST alpha in proximal
tubules only at thirty weeks gestation is unclear, but the
principal physiological change in the kidney at birth is its
gradually acquired ability to concentrate urine. Most resorp-
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Figure 10 Moderate staining for GST pi in an area of tubular
differentiation in Wilms' tumour (photograph taken under same
conditions as Figure 9) ( x 320).
tion of urine occurs in the proximal tubules. Fauldner et al.
(1987), in a biochemical investigation, also found that GST
mu was expressed at a low level throughout gestation unrelated to fetal age. In the present study the pattern of
immunostaining for each GST isoenzyme seen at 14 years of
age was similar to that of adult human kidney (Harrison etGLUTATHIONE S-TRANSFERASE EXPRESSION 839
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Figure 11 Very focal staining for GST alpha in tumour cells.
Most cells are completely negative ( x 320).
al., 1989a) and is consistent with published biochemical
studies (Singh et al., 1987; Fauldner et al., 1987).
Wilms' tumour shows morphological similarities to normal
fetal kidney and it is thought that it represents a disturbance
of normal tissue maturation (Lawler et al., 1977). Other
similarities exist. Recent work has shown that blastema in
nephroblastoma re-expresses the long-chain form of
polysialic acid present on the neural cell adhesion molecule
(Roth et al., 1988). This is a normal constituent of the fetal,
but not adult, kidney (Roth et al., 1988). Both fetal kidney
and Wilms' tumour blastema fail to express class I major
histocompatibility complex (MHC I) antigens, whereas dif-
ferentiated renal epithelium does express MHC I (Borthwick
et al., 1988). In this present study expression of GST pi in
tubules in both fetal kidney and Wilms' tumour has been
demonstrated. Within both groups the staining of tubules
varied in intensity, a feature also noted in immunostaining
for MHC I (Borthwick et al., 1988).
Of interest is the presence of detectable GST pi in the
blastema of 14 out of the 15 cases of Wilm's tumour.
Although the staining intensity was focally strong it was
usually only weak or moderate. This contrasts with adult
renal carcinoma where there is very intense, usually uniform,
staining of tumour cells for GST pi (Harrison et al., 1989b).
Most of the samples ofWilms' tumour failed to express other
GST isoenzymes at detectable methods using immunohis-
tochemistry unlike all the cases of renal carcinoma previously
studied (Harrison et al., 1989b). The 5' promoter region of
the GST pi gene in both rat and human contains the
TGACTCAG consensus sequence which is believed to be
responsive to phorbol ester and the ras oncogene (Cowell et
al., 1988). In Wilms' tumour low levels of Ha-ras mRNA are
expressed (Scott et al., 1985) whereas there is enhanced ex-
pression ofN-myc (Nisen et al., 1986). The low levels of GST
pi expression in Wilms' tumour therefore may be a reflection
of relative inactivity of ras gene expression.
It is interesting to speculate whether this difference in the
level of GST expression relates in some way to sensitivity of
the respective tumours to chemotherapy (Wolf et al., 1987).
in the present study no difference in individual outcome was
seen on the basis of GST immunostaining. However, as a
group, cases of Wilms' tumour tend to be responsive to
therapy whereas renal carcinoma, which expresses readily
detectable GST, is not. The concept of drug resistance in
tumours is unlikely to be so simple (Kaye, 1988).
Further studies are required to ascertain whether the ex-
pression of GST and other enzyme systems is related to
therapeutic sensitivity and whether there is modulation of
GST expression caused by treatment or in recurrent tumour.
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